• ISSN: 2349-6002
  • UGC Approved Journal No 47859

CANCER VACCINES: PIONEERING APPROACHES IN IMMUNOTHERAPY

  • Unique Paper ID: 166556
  • Volume: 11
  • Issue: 2
  • PageNo: 1240-1244
  • Abstract:
  • Cancer remains one of the leading causes of morbidity and mortality worldwide, with millions of new cases diagnosed each year. Despite significant advancements in conventional treatments such as surgery, chemotherapy, and radiation therapy, these modalities often come with severe side effects and are not universally effective. This has led to an increasing interest in harnessing the body's immune system to fight cancer, a strategy known as immunotherapy. Among the various forms of immunotherapy, cancer vaccines have emerged as a promising approach. Unlike traditional vaccines that are designed to prevent infectious diseases, cancer vaccines are developed to either prevent cancer in highrisk individuals or treat existing malignancies. These vaccines work by stimulating the immune system to recognize and attack cancer cells, which often evade immune detection by masquerading as normal cells. This review aims to provide a comprehensive overview of cancer vaccines, discussing their types, mechanisms of action, current state of clinical development, recent advances, and future directions. By exploring the evolving landscape of cancer vaccines, we seek to highlight their potential to transform cancer treatment and improve patient outcomes.

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 2
  • PageNo: 1240-1244

CANCER VACCINES: PIONEERING APPROACHES IN IMMUNOTHERAPY

Related Articles